D-Index & Metrics Best Publications
Research.com 2022 Best Scientist Award Badge

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 191 Citations 160,182 1,146 World Ranking 84 National Ranking 59
Best Scientists D-index 203 Citations 201,192 1,882 World Ranking 157 National Ranking 111

Research.com Recognitions

Awards & Achievements

2022 - Research.com Best Scientist Award

2005 - Potamkin Prize for Research in Pick's, Alzheimer's, and Related Diseases, American Academy of Neurology

2005 - Sedgwick Memorial Medal, American Public Health Association

2004 - Metlife Foundation Award for Medical Research in Alzheimer's Disease

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Cancer
  • Disease

His primary scientific interests are in Alzheimer's disease, Dementia, Internal medicine, Disease and Pathology. His primary area of study in Alzheimer's disease is in the field of Clinical Dementia Rating. While the research belongs to areas of Dementia, John C. Morris spends his time largely on the problem of Cognition, intersecting his research to questions surrounding Clinical psychology.

John C. Morris combines subjects such as Endocrinology and Oncology with his study of Internal medicine. In his study, which falls under the umbrella issue of Disease, Frontotemporal lobar degeneration is strongly linked to Genetics. His Cerebrospinal fluid study combines topics in areas such as Central nervous system and Amyloid.

His most cited work include:

  • The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease (9237 citations)
  • The Clinical Dementia Rating (CDR): Current version and scoring rules (6434 citations)
  • Current concepts in mild cognitive impairment. (3686 citations)

What are the main themes of his work throughout his whole career to date?

John C. Morris mostly deals with Alzheimer's disease, Internal medicine, Disease, Dementia and Pathology. His Alzheimer's disease research is multidisciplinary, incorporating elements of Cognition, Neuroscience, Cognitive decline, Biomarker and Degenerative disease. His studies in Internal medicine integrate themes in fields like Gastroenterology, Endocrinology and Oncology.

The concepts of his Disease study are interwoven with issues in Clinical trial and Neuroimaging. A large part of his Dementia studies is devoted to Clinical Dementia Rating. John C. Morris mostly deals with Amyloid in his studies of Pathology.

He most often published in these fields:

  • Alzheimer's disease (27.72%)
  • Internal medicine (26.06%)
  • Disease (21.46%)

What were the highlights of his more recent work (between 2017-2021)?

  • Alzheimer's disease (27.72%)
  • Internal medicine (26.06%)
  • Disease (21.46%)

In recent papers he was focusing on the following fields of study:

His scientific interests lie mostly in Alzheimer's disease, Internal medicine, Disease, Dementia and Oncology. His study looks at the intersection of Alzheimer's disease and topics like Cognition with Cognitive decline. His Internal medicine research incorporates elements of Gastroenterology and Endocrinology.

Disease is closely attributed to Positron emission tomography in his work. His studies deal with areas such as Pittsburgh compound B, Cerebrospinal fluid, Neurodegeneration and Atrophy as well as Biomarker. As part of his studies on Pathology, he often connects relevant subjects like White matter.

Between 2017 and 2021, his most popular works were:

  • Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study (409 citations)
  • Blood-brain barrier breakdown is an early biomarker of human cognitive dysfunction. (337 citations)
  • Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer’s disease (238 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Cancer
  • Disease

His primary areas of investigation include Internal medicine, Alzheimer's disease, Disease, Dementia and Biomarker. His biological study spans a wide range of topics, including Gastroenterology and Oncology. John C. Morris is interested in Presenilin, which is a branch of Alzheimer's disease.

He works mostly in the field of Disease, limiting it down to concerns involving Immunology and, occasionally, Neurology. In Dementia, John C. Morris works on issues like Asymptomatic, which are connected to Cohort. The study incorporates disciplines such as Clinical trial, Cerebrospinal fluid, Cross-sectional study, Pittsburgh compound B and Apolipoprotein E in addition to Biomarker.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

The Clinical Dementia Rating (CDR): Current version and scoring rules

John C. Morris.
Neurology (1993)

11160 Citations

The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease

Guy M. McKhann;Guy M. McKhann;David S. Knopman;Howard Chertkow;Bradley T. Hyman.
Alzheimers & Dementia (2011)

9237 Citations

Current concepts in mild cognitive impairment.

Ronald C. Petersen;Rachelle Doody;Alexander Kurz;Richard C. Mohs.
JAMA Neurology (2001)

5956 Citations

The consortium to establish a registry for alzheimer’s disease (CERAD). Part I. Clinical and neuropsychological assessment of alzheimer’s disease

J. C. Morris;A. Heyman;R. C. Mohs;J. P. Hughes.
Neurology (1989)

4759 Citations

Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17

M. Hutton;C. L. Lendon;P. Rizzu;M. Baker.
Nature (1998)

3532 Citations

Clinical and Biomarker Changes in Dominantly Inherited Alzheimer’s Disease

Randall J. Bateman;Chengjie Xiong;Tammie L.S. Benzinger;Anne M. Fagan.
The New England Journal of Medicine (2012)

2742 Citations

Erratum: Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease (Nature Genetics (2009) 41 (1088-1093))

D Harold;R Abraham;P Hollingworth;R Sims.
Nature Genetics (2013)

2731 Citations

Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease.

Denise Harold;Richard Abraham;Paul Hollingworth;Rebecca Sims.
Nature Genetics (2009)

2573 Citations

Tangles and plaques in nondemented aging and “preclinical” Alzheimer's disease

Joseph L. Price;John C. Morris.
Annals of Neurology (1999)

2221 Citations

Mild cognitive impairment represents early-stage Alzheimer disease.

John C. Morris;Martha Storandt;J. Phillip Miller;Daniel W. McKeel.
JAMA Neurology (2001)

2201 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing John C. Morris

Kaj Blennow

Kaj Blennow

University of Gothenburg

Publications: 875

Henrik Zetterberg

Henrik Zetterberg

University of Gothenburg

Publications: 862

Ronald C. Petersen

Ronald C. Petersen

Mayo Clinic

Publications: 505

Philip Scheltens

Philip Scheltens

Vrije Universiteit Amsterdam

Publications: 503

John Q. Trojanowski

John Q. Trojanowski

University of Pennsylvania

Publications: 454

Bruce L. Miller

Bruce L. Miller

University of California, San Francisco

Publications: 432

David A. Bennett

David A. Bennett

Rush University Medical Center

Publications: 416

Reisa A. Sperling

Reisa A. Sperling

Brigham and Women's Hospital

Publications: 401

David S. Knopman

David S. Knopman

Mayo Clinic

Publications: 386

William J. Jagust

William J. Jagust

Helen Wills Neuroscience Institute

Publications: 349

Clifford R. Jack

Clifford R. Jack

Mayo Clinic

Publications: 349

Giovanni B. Frisoni

Giovanni B. Frisoni

University of Geneva

Publications: 337

Dennis W. Dickson

Dennis W. Dickson

Mayo Clinic

Publications: 333

John R. Hodges

John R. Hodges

University of Sydney

Publications: 330

Harald Hampel

Harald Hampel

Université Paris Cité

Publications: 319

Paul M. Thompson

Paul M. Thompson

University of Southern California

Publications: 311

Trending Scientists

Desney S. Tan

Desney S. Tan

Microsoft (United States)

Sandip Sen

Sandip Sen

University of Tulsa

Erik Reinhard

Erik Reinhard

Technicolor (France)

Dimitrios I. Fotiadis

Dimitrios I. Fotiadis

University of Ioannina

Laurent Denoue

Laurent Denoue

Fuji Xerox (Japan)

Ignacio R. Matias

Ignacio R. Matias

Universidad Publica De Navarra

Wenjie Shen

Wenjie Shen

Dalian Institute of Chemical Physics

Bin Hu

Bin Hu

Wuhan University

Efstratios I. Kamitsos

Efstratios I. Kamitsos

National Hellenic Research Foundation

Brian E. Scheffler

Brian E. Scheffler

Agricultural Research Service

John McLauchlan

John McLauchlan

University of Glasgow

Kerry Gallagher

Kerry Gallagher

University of Rennes 1

Jennifer A.J. Dungait

Jennifer A.J. Dungait

University of Exeter

Barbara R. Foorman

Barbara R. Foorman

Florida State University

Toshio Miyata

Toshio Miyata

Tohoku University

Béla Merkely

Béla Merkely

Semmelweis University

Something went wrong. Please try again later.